Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone

Journal of Clinical Rheumatology

Volumn 16, Issue 3, 2010, Pages 143-145

  Hildebrand, Bernard A ^a   Arroyo, Ramon ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DYSPNEA; FATIGUE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FIBROSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYARTHRITIS; PRIORITY JOURNAL; SKIN BIOPSY; WEIGHT REDUCTION;

CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951087567     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181d59c59     Document Type: Article

References (14)

1. Gerami P, Schope JM, McDonald L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54:597-613.
2. Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol. 1975;111:241-245.
3. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626-636.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.
5. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis siné myositis). J Am Acad Dermatol. 1991;24:959-966.
6. Sontheimer RD. Dematomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20:387-408.
7. Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647-1654.
8. Suda T, Fujisawa T, Enomoto N, et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J. 2006;28:1005-1012.
9. Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60:2193-2200.
10. Miyazaki E, Ando M, Muramatsu T, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol. 2007;26:436-439.
11. Ideura G, Hanaoka M, Koizumi T, et al. Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases. Respir Med. 2007; 101:1406-1411.
12. Casado E, Gratacos J, Tolosa C, et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis. 2006;65:385-390.
13. Cosnes A, Amaudric F, Gherardi R, et al. Dermatomyositis without muscle weakness: long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 1995;131:1381-1385.
14. El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46:560-565.